Suppr超能文献

吸入沙丁胺醇、二丙酸倍氯米松及异丙托溴铵对部分慢性稳定型支气管哮喘患者黏液纤毛清除功能的影响

Effect of inhalation of salbutamol, beclomethasone dipropionate & ipratropium bromide on mucociliary clearance in some patients with chronic stable bronchial asthma.

作者信息

Guleria R, Singh T R, Sinha S, Padhy A K, Gupta K, Pande J N

机构信息

Department of Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.

出版信息

Indian J Med Res. 2003 Apr;117:158-63.

Abstract

BACKGROUND & OBJECTIVES: Asthma is now regarded as an inflammatory disease and bronchial inflammation may disrupt mucociliary function. Inhaled drugs may act by improving mucociliary function. The aim of the study was to investigate the effect of salbutamol, ipratropium bromide and beclomethasone on mucociliary clearance in patients with chronic stable asthma and to compare the efficacy of these drugs on mucociliary clearance.

METHODS

Ten patients with chronic stable asthma were enrolled in the study, but two patients did not complete the study. Patients with bronchial asthma were chosen on clinical grounds. (99m)Tc phytate radioaerosol generated through a nebulizer, was given to each patient on four days. After each administration the radioactivity over the thorax was constantly measured in sequential frame mode for 120 min. Radioactivity in the thorax was also measured after 24 h. A base-line pulmonary function test with reversibility was obtained. Salbutamol, ipratropium bromide, beclomethasone dipropionate and placebo inhalation were given randomly to each patient on four days.

RESULTS

The mean age of patients (n = 8) was 36 +/- 9.3 yr and mean duration of symptoms was 5 +/- 6.6 yr. There was no visual impression that mucociliary clearance was enhanced with any of the drugs. The time activity curves did not show any visually recognisable change in slope. In only one patient the curve tended to show a steeper slope with ipratropium inhalation. In the rest of the patients the curves showed no difference at all with medication when compared with placebo. All the quantitative indices analyzed by two-way ANOVA at the end of one and two hours were comparable for the three test drugs and placebo. None of the three test drugs demonstrated statistically significant mucociliary clearance effect compared with placebo. However, the temporal difference in airways clearance efficiency (ACE) was significant with beclomethasone and ipratropium bromide.

INTERPRETATION & CONCLUSION: Inhalation of any of the three drugs tested did not produce any immediate improvement in mucociliary clearance as compared to placebo in patients with stable bronchial asthma suggesting the need for further studies using higher doses of drugs for longer duration in a large sample.

摘要

背景与目的

哮喘目前被视为一种炎症性疾病,支气管炎症可能会破坏黏液纤毛功能。吸入药物可能通过改善黏液纤毛功能发挥作用。本研究的目的是调查沙丁胺醇、异丙托溴铵和倍氯米松对慢性稳定型哮喘患者黏液纤毛清除功能的影响,并比较这些药物在黏液纤毛清除功能方面的疗效。

方法

10例慢性稳定型哮喘患者纳入本研究,但2例患者未完成研究。根据临床标准选择支气管哮喘患者。通过雾化器产生的(99m)锝植酸盐放射性气溶胶,在4天内给予每位患者。每次给药后,以连续帧模式持续测量胸部放射性120分钟。24小时后也测量胸部放射性。进行了基线肺功能可逆性测试。在4天内,将沙丁胺醇、异丙托溴铵、二丙酸倍氯米松和安慰剂吸入剂随机给予每位患者。

结果

患者(n = 8)的平均年龄为36±9.3岁,平均症状持续时间为5±6.6年。没有直观印象表明任何一种药物能增强黏液纤毛清除功能。时间-活性曲线在斜率上没有显示出任何肉眼可识别的变化。仅1例患者吸入异丙托溴铵后曲线斜率趋于变陡。在其余患者中,与安慰剂相比,用药后的曲线没有差异。在1小时和2小时末通过双向方差分析分析的所有定量指标,三种受试药物和安慰剂之间具有可比性。与安慰剂相比,三种受试药物均未显示出统计学上显著的黏液纤毛清除效果。然而,倍氯米松和异丙托溴铵在气道清除效率(ACE)方面的时间差异具有显著性。

解读与结论

在稳定型支气管哮喘患者中,与安慰剂相比,吸入所测试的三种药物中的任何一种均未立即改善黏液纤毛清除功能,这表明需要在大样本中使用更高剂量的药物并延长用药时间进行进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验